Olcorolimus

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameOlcorolimus
Drug Alias NameMyolimusSDZ 227-943 NSAR-943SAR943NSAR943-NXA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsImmunosuppressants
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsCoronary Restenosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A